Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11M Buy
85,329
+10,278
+14% +$1.2M 0.12% 158
2026
Q1
$9.03M Buy
75,051
+2,547
+4% +$294K 0.11% 154
2025
Q4
$7.63M Buy
72,504
+16,223
+29% +$1.52M 0.1% 151
2025
Q3
$4.72M Sell
56,281
-3,899
-6% -$321K 0.06% 202
2025
Q2
$4.76M Buy
60,180
+20,838
+53% +$1.66M 0.07% 164
2025
Q1
$3.53M Buy
39,342
+27,185
+224% +$2.54M 0.05% 157
2024
Q4
$1.21M Buy
12,157
+1,561
+15% +$161K 0.02% 217
2024
Q3
$1.2M Buy
10,596
+7,079
+201% +$841K 0.02% 211
2024
Q2
$435K Sell
3,517
-129
-4% -$16.6K 0.01% 222
2024
Q1
$481K Buy
+3,646
New +$449K 0.01% 216

Other funds holding MRK

Vest Financial's MRK Position: Q2 2026 in Review

Vest Financial increased its Merck (MRK) stake by 14% in Q2 2026, buying an estimated $1.2M and bringing the position to 85,329 shares worth $11M. The position accounts for 0.12% of the portfolio, ranked #158.

Vest Financial first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. 1,598 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vest Financial held 85,329 shares of Merck worth $11M as of Q2 2026.
  • Vest Financial bought 10,278 Merck shares in Q2 2026, an estimated $1.2M.
  • Merck made up 0.12% of Vest Financial's portfolio in Q2 2026, its #158 holding.
  • Vest Financial first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • 1,598 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vest Financial's 13F filing for Q2 2026, filed 24 Jul 2026.